Microneedle Flu Vaccine Market Size, Share, Growth, and Industry Analysis, By Type (Solid Microneedle,Hollow Microneedle,Coated Microneedle,Dissolving Microneedle), By Application (Influenza A,Influenza B), Regional Insights and Forecast to 2035
Detailed TOC of Global Microneedle Flu Vaccine Market Research Report 2023
1 Microneedle Flu Vaccine Market Overview
1.1 Product Overview and Scope of Microneedle Flu Vaccine
1.2 Microneedle Flu Vaccine Segment by Type
1.2.1 Global Microneedle Flu Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Microneedle Flu Vaccine Segment by Application
1.3.1 Global Microneedle Flu Vaccine Market Value by Application: (2023-2029)
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Microneedle Flu Vaccine Revenue 2018-2029
1.4.2 Global Microneedle Flu Vaccine Sales 2018-2029
1.4.3 Global Microneedle Flu Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Microneedle Flu Vaccine Market Competition by Manufacturers
2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Microneedle Flu Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedle Flu Vaccine, Product Type & Application
2.7 Microneedle Flu Vaccine Market Competitive Situation and Trends
2.7.1 Microneedle Flu Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
2.7.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microneedle Flu Vaccine Retrospective Market Scenario by Region
3.1 Global Microneedle Flu Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Microneedle Flu Vaccine Global Microneedle Flu Vaccine Sales by Region: 2018-2029
3.2.1 Global Microneedle Flu Vaccine Sales by Region: 2018-2023
3.2.2 Global Microneedle Flu Vaccine Sales by Region: 2024-2029
3.3 Global Microneedle Flu Vaccine Global Microneedle Flu Vaccine Revenue by Region: 2018-2029
3.3.1 Global Microneedle Flu Vaccine Revenue by Region: 2018-2023
3.3.2 Global Microneedle Flu Vaccine Revenue by Region: 2024-2029
3.4 North America Microneedle Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Microneedle Flu Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Microneedle Flu Vaccine Sales by Country (2018-2029)
3.4.3 North America Microneedle Flu Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Microneedle Flu Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Microneedle Flu Vaccine Sales by Country (2018-2029)
3.5.3 Europe Microneedle Flu Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Microneedle Flu Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Microneedle Flu Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Microneedle Flu Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Microneedle Flu Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Microneedle Flu Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Microneedle Flu Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microneedle Flu Vaccine Sales by Type (2018-2029)
4.1.1 Global Microneedle Flu Vaccine Sales by Type (2018-2023)
4.1.2 Global Microneedle Flu Vaccine Sales by Type (2024-2029)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Microneedle Flu Vaccine Revenue by Type (2018-2029)
4.2.1 Global Microneedle Flu Vaccine Revenue by Type (2018-2023)
4.2.2 Global Microneedle Flu Vaccine Revenue by Type (2024-2029)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Microneedle Flu Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Microneedle Flu Vaccine Sales by Application (2018-2029)
5.1.1 Global Microneedle Flu Vaccine Sales by Application (2018-2023)
5.1.2 Global Microneedle Flu Vaccine Sales by Application (2024-2029)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Microneedle Flu Vaccine Revenue by Application (2018-2029)
5.2.1 Global Microneedle Flu Vaccine Revenue by Application (2018-2023)
5.2.2 Global Microneedle Flu Vaccine Revenue by Application (2024-2029)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Microneedle Flu Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GC Pharma
6.2.1 GC Pharma Corporation Information
6.2.2 GC Pharma Description and Business Overview
6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
6.2.5 GC Pharma Recent Developments/Updates
6.3 Debiotech
6.3.1 Debiotech Corporation Information
6.3.2 Debiotech Description and Business Overview
6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
6.3.5 Debiotech Recent Developments/Updates
6.4 NanoPass Technologies
6.4.1 NanoPass Technologies Corporation Information
6.4.2 NanoPass Technologies Description and Business Overview
6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
6.4.5 NanoPass Technologies Recent Developments/Updates
6.5 Corium International
6.5.1 Corium International Corporation Information
6.5.2 Corium International Description and Business Overview
6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
6.5.5 Corium International Recent Developments/Updates
6.6 Becton Dickinson and Company
6.6.1 Becton Dickinson and Company Corporation Information
6.6.2 Becton Dickinson and Company Description and Business Overview
6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
6.6.5 Becton Dickinson and Company Recent Developments/Updates
6.7 FluGen
6.6.1 FluGen Corporation Information
6.6.2 FluGen Description and Business Overview
6.6.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 FluGen Microneedle Flu Vaccine Product Portfolio
6.7.5 FluGen Recent Developments/Updates
6.8 CosMED Pharmaceuticals
6.8.1 CosMED Pharmaceuticals Corporation Information
6.8.2 CosMED Pharmaceuticals Description and Business Overview
6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
6.9 Microdermics and OraSure Technologies
6.9.1 Microdermics and OraSure Technologies Corporation Information
6.9.2 Microdermics and OraSure Technologies Description and Business Overview
6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedle Flu Vaccine Industry Chain Analysis
7.2 Microneedle Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedle Flu Vaccine Production Mode & Process
7.4 Microneedle Flu Vaccine Sales and Marketing
7.4.1 Microneedle Flu Vaccine Sales Channels
7.4.2 Microneedle Flu Vaccine Distributors
7.5 Microneedle Flu Vaccine Customers
8 Microneedle Flu Vaccine Market Dynamics
8.1 Microneedle Flu Vaccine Industry Trends
8.2 Microneedle Flu Vaccine Market Drivers
8.3 Microneedle Flu Vaccine Market Challenges
8.4 Microneedle Flu Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer